Drug Manufacturers - Specialty & Generic | Healthcare
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. It serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Market Cap
183312842752
Current Price
1157.3
52 Week Range
701.8 - 1309.9
Previous Close
1146.2
Open
1133.1
Sector
Healthcare
Address
1A, Sector 16A, , Noida, 201301, India
Phone
+91-12043-61000
Fax
+91-12042-34881
Website
https://www.jubilantpharmova.com
Day Low
1133.1
Day High
1164.0
Dividend Yield
0.44
PE Ratio
21.856468
Earnings Per Share
52.95
Beta
0.803
EBITDA
11736999936
Book Value
395.411
EPS
35.5
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Priyavrat Bhartia MBA | MD & Director | 48 | 1976 |
Mr. Arjun Shanker Bhartia | Joint MD & Director | 37 | 1987 |
Mr. Arvind Chokhany | Group CFO & Whole-Time Director | 52 | 1972 |
Mr. Prakash Chandra Bisht B.Com., CA | Executive VP of Group Accounts | 59 | 1965 |
Surajit Pal | Head of Investor Relations | - | - |
Mr. Sanjay Gupta A.C.M.A., B.Com., L.L.B. | Executive VP & Head of Legal | 58 | 1966 |
Mr. Naresh Kapoor | Company Secretary & Compliance Officer | 50 | 1974 |
Shantanu Jha | Group Chief Human Resources Officer | - | - |
Mr. Rajagopal Sankaraiah B.Sc., CA, F.C.A. | Advisor | 65 | 1959 |
Mr. A. P. Srivastava B.A., BA | Senior Vice President of Corporate Affairs | 78 | 1946 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.